Font Size: a A A
Keyword [Nonvalvular atrial fibrillation]
Result: 61 - 80 | Page: 4 of 7
61. Efficacy And Safety Of Dabigatran In The Senile Patients Nonvalvular Atrial Fibrillation
62. Anticoagulation Treatment Using Dabigatran During Perioperative Period Of Catheter Ablation Of Nonvalvular Atrial Fibrillation: The Effects Of Low Molecular Weight Heparin Bridging And Not Bridging On ACT Value And Clinical Events
63. Correlation Between Fibrinogen To Albumin Ratio And CHA2DS2-VASc Score In Patients With Nonvalvular Atrial Fibrillation
64. Predictive Value Of Cystatin C And Left Atrial Volume Index For Early Recurrence After Catheter Ablation Of Patients With Atrial Fibrillation
65. Predictive Value Of LAF Combined With Serum ST2 On Recurrence Of Paroxysmal Atrial Fibrillation (Non-valvular)
66. Analysis Of Risk Factors For Ischemic Stroke In Patients With Nonvalvular Atrial Fibrillation
67. Correlated Research Between Nonvalvular Atrial Fibrillation And The Ratio Of Peripheral White Blood Cells Count And Subtype
68. The Safety And Efficacy Events Of Left Atrial Appendage Closure In Stroke Prevention In Patients With Nonvalvular Atrial Fibrillation:A Meta-Analysis Of Single Group Rate
69. The Efficacy And Safety Of Dabigatrol In Elderly Patients With Non-valvular Atrial Fibrillation Complicated By Renal Insufficiency
70. An Observational Study Of Novel Oral Anticoagulants In Elderly Patients With Nonvalvular Atrial Fibrillation
71. Analysis Of The Risk Factors Of Thrombotic Events In CHA2DS2-VASc=0 Patients With Nonvalvular Atrial Fibrillation
72. The Effect Of Left Atrial Appendage Occlusion And Oral Anticoagulation Drugs On Stroke Prevention In Patients With Nonvalvular Atrial Fibrillation:A Meta-Analysis
73. Efficacy And Safety Of Rivaroxaban In Anticoagulant Therapy For Patients With Nonvalvular Atrial Fibrillation
74. Efficacy And Safety Of Dabigatran And Rivaroxaban In The Treatment Of Patients With Nonvalvular Atrial Fibrillation
75. Association Between Platelet Count And The Risk Of Bleeding Among Patients With Nonvalvular Atrial Fibrillation Taking Dabigatran After Radiofrequency Ablation
76. Distribution Of TCM Syndromes In Nonvalvular Atrial Fibrillation With Type 2 Diabetes And Its Correlation With Glycated Hemoglobin And Hypersensitive C-Reactive Protein
77. Relationship Between Tgf-β And Periostin Protein And Non-valvular Atrial Fibrillation And Its Mechanism
78. Changes And Clinical Significance Of Serum C-reactive Protein,Red Blood Cell Distribution Width And Neutrophil/Lymphocyte Percentage In Patients With Nonvalvular Atrial Fibrillation
79. Study On The Safety Of Anticoagulant Therapy And Biomarkers In Elderly Patients With Nonvalvular Atrial Fibrillation
80. Three-Dimensional Speckle Tracking Imaging In Assessment Of The Left Atrial Function And Synchrony In Patients With Nonvalvular Atrial Fibrillation
  <<First  <Prev  Next>  Last>>  Jump to